Hypertension in hemodialysis patients

M. Querques, P. Manunta

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Hypertension confers higher cardiovascular (CV) risk in hemodialysis (HD) patients, perhaps because patients with CKD have a high burden of traditional cardiovascular risk factors in addition to a range of non-traditional risk factors such as anemia, left ventricular hypertrophy, inflammation and abnormal metabolism of calcium and phosphate. Potentially beneficial therapies are sometime under used in patients with end stage renal disease and are rarely studied in patients on dialysis. Newer studies using home BP and ambulatory BP during 24 hours have provided a narrower range of BP values that may reduce CV risk. Ambulatory blood pressure (BP) monitoring is a growing tool for hypertension evaluation along with changes in vascular compliance. Home BP values on interdialytic days are practical and also demonstrate good correlations with ambulatory readings. In this review, we describe the epidemiology, the pathogenetic mechanisms that underlie blood pressure over load in dialysis patients and outline traditional and non traditional cardiovascular risk factors that are relevant in this population.

Original languageEnglish
Pages (from-to)41-50
Number of pages10
JournalMinerva Urologica e Nefrologica
Volume62
Issue number1
Publication statusPublished - Mar 2010

Fingerprint

Renal Dialysis
Blood Pressure
Hypertension
Dialysis
Ambulatory Blood Pressure Monitoring
Left Ventricular Hypertrophy
Compliance
Chronic Kidney Failure
Blood Vessels
Anemia
Reading
Epidemiology
Inflammation
Population
Therapeutics

Keywords

  • Antihypertensive agents
  • Dialysis
  • Hypertension

ASJC Scopus subject areas

  • Nephrology
  • Urology

Cite this

Hypertension in hemodialysis patients. / Querques, M.; Manunta, P.

In: Minerva Urologica e Nefrologica, Vol. 62, No. 1, 03.2010, p. 41-50.

Research output: Contribution to journalArticle

Querques, M. ; Manunta, P. / Hypertension in hemodialysis patients. In: Minerva Urologica e Nefrologica. 2010 ; Vol. 62, No. 1. pp. 41-50.
@article{9167573db329489da77db63cfb775cee,
title = "Hypertension in hemodialysis patients",
abstract = "Hypertension confers higher cardiovascular (CV) risk in hemodialysis (HD) patients, perhaps because patients with CKD have a high burden of traditional cardiovascular risk factors in addition to a range of non-traditional risk factors such as anemia, left ventricular hypertrophy, inflammation and abnormal metabolism of calcium and phosphate. Potentially beneficial therapies are sometime under used in patients with end stage renal disease and are rarely studied in patients on dialysis. Newer studies using home BP and ambulatory BP during 24 hours have provided a narrower range of BP values that may reduce CV risk. Ambulatory blood pressure (BP) monitoring is a growing tool for hypertension evaluation along with changes in vascular compliance. Home BP values on interdialytic days are practical and also demonstrate good correlations with ambulatory readings. In this review, we describe the epidemiology, the pathogenetic mechanisms that underlie blood pressure over load in dialysis patients and outline traditional and non traditional cardiovascular risk factors that are relevant in this population.",
keywords = "Antihypertensive agents, Dialysis, Hypertension",
author = "M. Querques and P. Manunta",
year = "2010",
month = "3",
language = "English",
volume = "62",
pages = "41--50",
journal = "Minerva Urologica e Nefrologica",
issn = "0393-2249",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "1",

}

TY - JOUR

T1 - Hypertension in hemodialysis patients

AU - Querques, M.

AU - Manunta, P.

PY - 2010/3

Y1 - 2010/3

N2 - Hypertension confers higher cardiovascular (CV) risk in hemodialysis (HD) patients, perhaps because patients with CKD have a high burden of traditional cardiovascular risk factors in addition to a range of non-traditional risk factors such as anemia, left ventricular hypertrophy, inflammation and abnormal metabolism of calcium and phosphate. Potentially beneficial therapies are sometime under used in patients with end stage renal disease and are rarely studied in patients on dialysis. Newer studies using home BP and ambulatory BP during 24 hours have provided a narrower range of BP values that may reduce CV risk. Ambulatory blood pressure (BP) monitoring is a growing tool for hypertension evaluation along with changes in vascular compliance. Home BP values on interdialytic days are practical and also demonstrate good correlations with ambulatory readings. In this review, we describe the epidemiology, the pathogenetic mechanisms that underlie blood pressure over load in dialysis patients and outline traditional and non traditional cardiovascular risk factors that are relevant in this population.

AB - Hypertension confers higher cardiovascular (CV) risk in hemodialysis (HD) patients, perhaps because patients with CKD have a high burden of traditional cardiovascular risk factors in addition to a range of non-traditional risk factors such as anemia, left ventricular hypertrophy, inflammation and abnormal metabolism of calcium and phosphate. Potentially beneficial therapies are sometime under used in patients with end stage renal disease and are rarely studied in patients on dialysis. Newer studies using home BP and ambulatory BP during 24 hours have provided a narrower range of BP values that may reduce CV risk. Ambulatory blood pressure (BP) monitoring is a growing tool for hypertension evaluation along with changes in vascular compliance. Home BP values on interdialytic days are practical and also demonstrate good correlations with ambulatory readings. In this review, we describe the epidemiology, the pathogenetic mechanisms that underlie blood pressure over load in dialysis patients and outline traditional and non traditional cardiovascular risk factors that are relevant in this population.

KW - Antihypertensive agents

KW - Dialysis

KW - Hypertension

UR - http://www.scopus.com/inward/record.url?scp=77953520483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953520483&partnerID=8YFLogxK

M3 - Article

C2 - 20424569

AN - SCOPUS:77953520483

VL - 62

SP - 41

EP - 50

JO - Minerva Urologica e Nefrologica

JF - Minerva Urologica e Nefrologica

SN - 0393-2249

IS - 1

ER -